ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

DCE Board Approves Support Contract Recompetition

July 6, 1990

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980

CT Screening for Lung Cancer Unproven; Limit Use to Trials, Chest Physicians Urge.

September 14, 2007

NCI to Seek Concept Approval For Continuing Group Outreach Program; Five CCOP Proposals Reviewed

July 15, 1983